Evidence Hub

Gut Microbiome Modulation and Outcomes of Immune Checkpoint Inhibitors in Solid Tumors: A Secondary Qualitative Review

Chun-Gang Fan, E. Girsang, Silvia Fransisca

International Journal of Drug Delivery Technology, 2026

Abstract

ICI has revolutionized the treatment of solid tumors, but durable response has only been observed in a minority

of patients, and traditional biomarkers are not sufficient to explain the heterogeneity. Indeed, an increasing body

of translational evidence suggests that the gastrointestinal tract microbiome is not merely correlational but a host

determinant that can be remodeled to influence immune tone, treatment response, and toxicity. Synthesizing

clinical evidence on gut microbiome modulation in clinical primaries and outcomes of immune checkpoint

inhibitors in solid tumors, this secondary qualitative analysis has a thematic focus on response, survival, and

mechanistic plausibility. Eligible English language studies based on citation chasing were searched through a

structured search of PubMed, Europe PMC, Crossref, and Google Scholar. The findings synthesis involved fifteen

primary studies, and theoretical framing and discussion were conducted by a separate review of the literature.

Three common patterns were found in the thematic analysis. First, responder phenotypes were repeatedly

associated with higher microbial diversity and microbial enrichment, including Akkermansia, Ruminococcaceae,

Faecalibacterium, and Bifidobacterium. Second, in certain environments, uncontrolled exposure to antibiotics

and, in others, uncontrolled exposure to probiotics seemed to undermine the integrity of the ecological response

and the effectiveness of checkpoints, even though confounding is…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free